Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Varenicline or Nicotine Replacement Products Sample for the Promotion of Smoking Cessation in Current Smokers

Trial Status: closed to accrual

This clinical trial examines what happens when current smokers are given a free sample of varenicline or nicotine replacement products (patches or lozenges) to help stop or reduce smoking. Smoking causes a number of deaths and diseases, including heart disease and cancer. All smokers are advised to quit. Varenicline is a drug that both reduces cravings for and decreases the pleasurable effects of cigarettes and other tobacco products. Nicotine replacement products reduce cravings for cigarettes. Information gained from this study may help researchers evaluate new methods of how varenicline affects smoking behavior.

Have a question?
We're here to help

Chat with us: LiveHelp
Call us: 1-800-4-CANCER
(1-800-422-6237)

Which trials are right for you?

Use the checklist in our guide to gather the information you’ll need.